Citeline Podcasts
Episodes
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
22 Dec 2025
Contributed by Lukas
本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年12月19日当周的生物制药行业的商业动态。本期节目采用人...
Scrip's Five Must-Know Things - Dec. 22, 2025
22 Dec 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended December 19, 2025. This episode was produced with the hel...
“We Are On The Cusp Of A Real Revolution”: OHC Rare Disease Center Boosts Innovation
19 Dec 2025
Contributed by Lukas
Matthew Wood, director and chief scientific officer at Oxford-Harrington Rare Disease Center, discusses the state of rare disease R&D, the evolving la...
Scrip Awards Podcast, 2025 Winners
19 Dec 2025
Contributed by Lukas
This podcast brings you highlights from Scrip Awards 2025, including wins for AstraZeneca, Syndax, Akeso and Summit Therapeutics and the Lifetime Achi...
Datamonitor Healthcare Podcast: A Deep Dive into Dry AMD
19 Dec 2025
Contributed by Lukas
Emma Wille and Summer Colling speak with ophthalmology expert, Joseph Jacob, to discuss the latest developments in dry age-related macular degeneratio...
Scrip M&A Podcast: PwC's Dealmaking Preview for 2026
16 Dec 2025
Contributed by Lukas
Scrip senior writer Joseph Haas and PwC analyst Roel Van den Akker look back on biopharma sector dealmaking in 2025, why deal values rose from 2024's ...
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
15 Dec 2025
Contributed by Lukas
本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年12月12日当周的生物制药行业的商业动态。本期节目采用人...
Scrip's Five Must-Know Things - Dec. 15, 2025
15 Dec 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended December 12, 2025. This week, a focus on five key results...
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
08 Dec 2025
Contributed by Lukas
本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年12月5日当周的生物制药行业的商业动态。本期节目采用人...
Scrip's Five Must-Know Things - Dec. 8, 2025
08 Dec 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended December 5, 2025. In this episode: Trump’s UK drug pric...
Overcoming Drug Resistance In Oncology With Kairos Pharma's Neil Bhowmick
05 Dec 2025
Contributed by Lukas
Drug resistance derails even the most advanced cancer treatments, but what if we could restore sensitivity to existing therapies instead of starting o...
Drug Fix: Understanding the US FDA’s CDER Leadership Shuffle
05 Dec 2025
Contributed by Lukas
Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith and Editor-in-Chief Nielsen Hobbs break down the pending retirement of C...
【3分で解説 #世界のファーマ】第27回 中国バイオ企業の成長 5つのテーマ (Japanese-language podcast)
01 Dec 2025
Contributed by Lukas
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で...
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
01 Dec 2025
Contributed by Lukas
本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年11月28日当周的生物制药行业的商业动态。本期节目采用人...
Scrip's Five Must-Know Things - Dec. 1, 2025
01 Dec 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended November 28, 2025. In this episode: 2027 Medicare price ...
글로벌 바이오 리더들, M&A 열기 속 낙관론 확산 (Korean-language podcast)
28 Nov 2025
Contributed by Lukas
최근 런던에서 열린 Jefferies 글로벌 헬스케어 컨퍼런스를 취재한 Scrip기사를 요약한 내용입니다 https://insights.citel...
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
25 Nov 2025
Contributed by Lukas
本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年11月21日当周的生物制药行业的商业动态。本期节目采用人...
Scrip's Five Must-Know Things - Nov. 25, 2025
25 Nov 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended November 21, 2025. In this episode: obesity beyond GLP-1s...
Charles River CSO Calls For Collaboration On Non-Animal Models
24 Nov 2025
Contributed by Lukas
Charles River’s CSO Julie Frearson outlines the FDA’s planned transition away from animal testing, changing attitudes to artificial intelligence, ...
Over The Counter Special: Enabling Digital Self-Care, With PAGB’s Michelle Riddalls
19 Nov 2025
Contributed by Lukas
The UK’s consumer healthcare industry association, PAGB is publishing a series of blog posts for Self-Care Week – an annual awareness campaign in ...
Digital Health Roundup: BCIs Surge Ahead, Oura Eyes BP Clearance, AI Faces New Scrutiny
18 Nov 2025
Contributed by Lukas
In this week’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights her interviews with leaders at brain-computer interface developers...
Over The Counter Special: Unlocking Switch-Driven Growth, With PAGB’s Michelle Riddalls
18 Nov 2025
Contributed by Lukas
The UK’s consumer healthcare industry association, PAGB is publishing a series of blog posts for Self-Care Week – an annual awareness campaign in ...
Data-Driven Insights Reveal The Growth Engines Powering 2026 Life Sciences
17 Nov 2025
Contributed by Lukas
In this special In Vivo podcast episode, executive editor Lucie Ellis-Taitt is joined by an expert panel of Citeline journalists – Ashley Yeo, David...
EY's Arda Ural on IPOs, Financial Markets and Tarrifs
13 Nov 2025
Contributed by Lukas
After two of the toughest years in biotech history, are we finally seeing a turnaround? EY's Arda Ural discusses the long-awaited recovery in biotech ...
Datamonitor Healthcare Podcast: ESMO 2025
12 Nov 2025
Contributed by Lukas
Summer Colling and Emma Wille speak with Nkiru Ibeanu, Anna Simmons, and David Dahan from the oncology team about some of the most exciting data prese...
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
10 Nov 2025
Contributed by Lukas
本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年11月1日当周的生物制药行业的商业动态。本期节目采用人...
Scrip's Five Must-Know Things - Nov. 10, 2025
10 Nov 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended November 1, 2025. In this episode: Pfizer’s unwavering ...
Drug Fix: Examining George Tidmarsh’s Departure As Head Of US FDA’s Drug Center
07 Nov 2025
Contributed by Lukas
Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs take a deep ...
Podcast: Beyond The Checkpoint — Next-Gen Strategies In Immuno-Oncology
06 Nov 2025
Contributed by Lukas
Join Sarah Anderson, Therapeutic Strategy Director, Oncology at Novotech, and Izabela Chmielewska from Citeline as they explore how next-generation im...
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
04 Nov 2025
Contributed by Lukas
本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年10月31日当周的生物制药行业的商业动态。本期节目采用人...
Scrip's Five Must-Know Things - Nov. 4, 2025
04 Nov 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended October 31, 2025. In this episode: third quarter dealmaki...
Drug Fix: US FDA Streamlines Biosimilar Development Requirements, Clarifies Inspection Reform
31 Oct 2025
Contributed by Lukas
Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs consider the impact of the US Food and Drug Ad...
Decoding Cell Differentiation: How AI Foundation Models Are Reshaping Regenerative Medicine
31 Oct 2025
Contributed by Lukas
What if we could train AI to understand how stem cells become any cell type in the human body? In this episode of the In Vivo Podcast, host David Wild...
Scrip M&A Podcast: What's Next For Dealmaking In The Obesity Space?
31 Oct 2025
Contributed by Lukas
Joseph Haas, senior writer, Scrip, speaks to guest panelists Robert Darwin, partner, Sidley law firm, and Arda Ural, Americas Life Sciences Leader, EY...
국내 바이오텍 펀딩 활성화를 위해 새로운 촉매제 필요 (Korean-language podcast)
31 Oct 2025
Contributed by Lukas
스톤브릿지벤쳐스의 김현기 상무는 Scrip과의 인터뷰에서 벤처캐피탈의 국내 바이오 투심 회복을 제약하는 요인과...
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
27 Oct 2025
Contributed by Lukas
本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年10月24日当周的生物制药行业的商业动态。本期节目采用人...
Scrip's Five Must-Know Things - Oct. 27, 2025
27 Oct 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended October 24, 2025. In this episode we focus on the most si...
Drug Fix: Another FDA Inspection Reorg, Industry Navigating New DTC Landscape
24 Oct 2025
Contributed by Lukas
Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs explain the ...
Winning Biotech Investors Through Strategic Partnerships and Trial Innovation
22 Oct 2025
Contributed by Lukas
Biotech funding is tougher than ever, but some companies still win big. Join Claire Riches, VP, Clinical Solutions, Citeline and Alistair McDonald, CE...
Innovating Autoimmune Treatment with In Vivo CAR-T
21 Oct 2025
Contributed by Lukas
As the potential of in vivo CAR-T therapy moves closer to clinical reality, biotech innovators are reimagining what’s possible in autoimmune disease...
How Olon’s fully integrated, end-to-end ADC capabilities drive quality and scale
20 Oct 2025
Contributed by Lukas
Hear experts Matthieu Culié and Alessandro Agosti as they discuss how Olon stands out in a competitive landscape through its fully integrated end-to-...
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
20 Oct 2025
Contributed by Lukas
本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年10月17日当周的生物制药行业的商业动态。本期节目采用人...
Scrip's Five Must-Know Things - Oct. 20, 2025
20 Oct 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended October 17, 2025. In this episode: big pharma still sees ...
Drug Fix: US FDA Involved In Astra Zeneca’s Drug Pricing Deal, DOJ’s Off-Label Promotion Policy
17 Oct 2025
Contributed by Lukas
Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith and Editor-in-Chief Nielsen Hobbs discuss the reasons US Food and Drug A...
Adalvo: Exploring European B2B Pharma’s Next Steps
17 Oct 2025
Contributed by Lukas
Adalvo: Exploring European B2B Pharma’s Next Steps by Citeline
Lupus Clinical Development Enters a New Era of Innovation
16 Oct 2025
Contributed by Lukas
Join host David Wild as he speaks with Stacie Bell, chief clinical research officer at Lupus Therapeutics, about the dramatic transformation happening...
Essential Pharma – Following A Patient First Philosophy
15 Oct 2025
Contributed by Lukas
In Vivo spoke with Emma Johnson, CEO of Essential Pharma, to discuss the company's strategic priorities and plans for growth as it expands its portfol...
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
14 Oct 2025
Contributed by Lukas
本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年10月10日当周的生物制药行业的商业动态。本期节目采用人...
Scrip's Five Must-Know Things - Oct. 14, 2025
14 Oct 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended October 10, 2025. In this episode: biopharma financing re...
Cereno Scientific Turns To Old Drug For Rare Cardiopulmonary Diseases
10 Oct 2025
Contributed by Lukas
Cereno Scientific CEO Sten Sörensen discusses how his company is repurposing a 60-year-old epilepsy drug as a potential game-changer for pulmonary ar...
Defining the Next Era of Disruption
07 Oct 2025
Contributed by Lukas
Listen now as Citeline speaks with top executives from Perceptive to understand eClinical’s major reset and what it means for the future of clinical...
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Oct.7, 2025
07 Oct 2025
Contributed by Lukas
本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年10月3日当周的生物制药行业的商业动态。本期节目采用人...
Celebrating Europe’s Consumer Health Best Practice, With AESGP’s Luis Rhodes Baiao
06 Oct 2025
Contributed by Lukas
Celebrating Europe’s Consumer Health Best Practice, With AESGP’s Luis Rhodes Baiao The Association of the European Self-Care Industry, or AESGP, h...
Scrip's Five Must-Know Things - Oct. 6, 2025
06 Oct 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended October 3, 2025. In this episode: Pfizer’s backroom US ...
Drug Fix: Government Shutdown’s Impact On US FDA, Pfizer Inks Drug Pricing Deal
03 Oct 2025
Contributed by Lukas
Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, and senior editors Sue Sutter and Cathy Kelly consider the impact of th...
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Sept.30, 2025
30 Sep 2025
Contributed by Lukas
本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年9月26日当周的生物制药行业的商业动态。本期节目采用人...
Scrip's Five Must-Know Things - Sept. 30, 2025
30 Sep 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended September 26, 2025. In this episode: Pfizer jumps back in...
The Generics Bulletin Podcast: Talking with AAM president and CEO John Murphy
26 Sep 2025
Contributed by Lukas
Generics Bulletin editor Dave Wallace talks to John Murphy III, president and CEO of the US Association for Accessible Medicines, about the associatio...
3分で解説 #世界のファーマ】第26回 欧州の先発医薬品 米国関税15％適用へ (Japanese-language podcast) Sept.24, 2025
24 Sep 2025
Contributed by Lukas
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で...
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Sept.22, 2025
22 Sep 2025
Contributed by Lukas
本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年9月19日当周的生物制药行业的商业动态。本期节目采用人...
Scrip's Five Must-Know Things - September 22, 2025
22 Sep 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended September 19, 2025. In this episode: GSK announces US inv...
ICROM on Innovation in HPAPI & Crystallization
19 Sep 2025
Contributed by Lukas
Hear from ICROM CEO Pierfrancesco Morosini and HOLODIAG GM Pierric Marchand as they discuss how the company is advancing HPAPI development, solid-stat...
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Sept.16, 2025
16 Sep 2025
Contributed by Lukas
本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年9月12日当周的生物制药行业的商业动态。 本期要闻——诺...
Scrip's Five Must-Know Things - September 16, 2025
16 Sep 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended September 12, 2025. In this episode: Novo Nordisk cuts 9,...
Drug Fix: US FDA DTC Ad Crackdown Emerges From MAHA Report
12 Sep 2025
Contributed by Lukas
Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter, and Editor-in-Chief Nielsen Hobbs look at the...
Drive Early CRO Engagement to Optimize Funding, Trial Design, and Recruitment in Biotech
12 Sep 2025
Contributed by Lukas
What makes a biotech-CRO partnership truly work? Claire Riches, VP, Clinical Solutions, Citeline, and Matt Simmons, Senior Director, Oncology Strategy...
Why Local Matters: A Leadership Perspective on Community-Based Trials
09 Sep 2025
Contributed by Lukas
Community based trials are reshaping clinical research, broadening patient access and accelerating timelines. Discover the drivers, challenges and fut...
From Abandonment To Opportunity In Pediatric Pharma
08 Sep 2025
Contributed by Lukas
In Vivo spoke with Annette Bakker, CEO of the Children’s Tumor Foundation, a medical research foundation developing an innovative approach to revivi...
Scrip's Five Must-Know Things - September 5, 2025
08 Sep 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended September 5, 2025. In this episode: the US MASH market af...
Is It Better To Be A Sustainability ‘Shaper’ Or ‘Staller’? With PA Consulting’s Rhea Patten
07 Sep 2025
Contributed by Lukas
For today’s consumers, sustainability is an expectation rather than a luxury, according to PA Consulting’s latest Brand Impact Index. In other wor...
Drug Fix: US FDA Drops Offit, Others From Adcomms, Releases Unapproved Product Rejection Letters
05 Sep 2025
Contributed by Lukas
Pink Sheet Executive Editor Derrick Gingery, Managing Editor Bridget Silverman, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs consider th...
China Biopharma English-Language Podcast: China Innovative Drugs And Commercial Insurance
02 Sep 2025
Contributed by Lukas
In this episode of the China Biopharma English-language Podcast, Shanghai-based senior reporter Xu Hu talks about the release for the first time by Ch...
Scrip's Five Must-Know Things - Sept. 1, 2025
01 Sep 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended August 29, 2025. In this episode: Lilly’s orforglipron ...
Drug Fix: US FDA Changes COVID-19 Vaccine Labeling, Reimbursement Confusion Rises
29 Aug 2025
Contributed by Lukas
Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith and Senior Editor Sue Sutter discuss the impact of US Food and Drug Admi...
Navigating What’s Next for Global Drug Development: What Sponsors Need to Know
29 Aug 2025
Contributed by Lukas
As global regulatory expectations evolve, biotech sponsors face growing pressure to make smarter, earlier decisions about where and how to run their t...
VC가 한발 물러설 때 바이오 기업의 대체 자금원은? (Korean-language podcast)
29 Aug 2025
Contributed by Lukas
전통적 벤처캐피털이 점점 더 신중하고 선별적인 투자 성향으로 변하면서 바이오 기업들이 새로운 자본 조달 경로...
【3分で解説 #世界のファーマ】第25回 中国、民間保険で新薬のアクセス拡大へ
28 Aug 2025
Contributed by Lukas
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で...
How To ‘Vibe’ With Consumers, With PA Consulting’s Rhea Patten
26 Aug 2025
Contributed by Lukas
Despite the recent pressure on their finances, consumers are rejecting the idea of choosing brands based on cost alone, according to PA Consulting’s...
Scrip's Five Must-Know Things - August 25, 2025
25 Aug 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended August 22, 2025. In this episode: Madrigal regains MASH l...
Merck KGaA's Vision For Making Digital Health Redundant
22 Aug 2025
Contributed by Lukas
Merck KGaA's Emre Ozcan outlines the company's systematic approach to integrating digital solutions across the care continuum in specialty pharmaceuti...
Tevard CEO Sees Hope for HIs Daughter In His Company's tRNA Platform
18 Aug 2025
Contributed by Lukas
Tevard Biosciences CEO Daniel Fischer discusses how engineered suppressor tRNAs enable read-through of premature stop codons to restore full-length pr...
Scrip's Five Must-Know Things - August 15, 2025
18 Aug 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended August 15, 2025. In this episode: a look at the likely to...
Scrip's Five Must-Know Things - August 8, 2025
12 Aug 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended August 8, 2025. In this episode: Trump ups pressure on MF...
Turning Global Ambition Into Local Reality, With Haleon’s Jo Cooper
11 Aug 2025
Contributed by Lukas
It’s been about three years since Haleon became a standalone self-care company. Since then, the firm has announced an ambitious plan to reach one bi...
Aurigene Oncology CEO On Biotech Valuations, CAR-Ts And Reimbursement Models
05 Aug 2025
Contributed by Lukas
Dr Murali Ramachandra, CEO of Aurigene Oncology, talks to Anju Ghangurde about the tough biotech funding environment, promising pipeline assets includ...
Poolbeg CEO On The Biotech’s Big Bet On Small Molecules
04 Aug 2025
Contributed by Lukas
In the latest episode of the In Vivo Podcast, Jeremy Skillington, CEO of Poolbeg Pharma, discussed the company’s ambitious pipeline and strategic di...
Scrip's Five Must-Know Things - August 4, 2025
04 Aug 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended August 1, 2025. In this episode: EU tariff deal leaves qu...
Exploring Ex-US Markets to Reduce Risk for Your Clinical Trials
01 Aug 2025
Contributed by Lukas
Amid growing uncertainty in the U.S. regulatory landscape, sponsors are increasingly looking to ex-U.S. markets as a strategic way to reduce clinical ...
The Patient Journey: Key R&D Considerations In Rheumatoid Arthritis
29 Jul 2025
Contributed by Lukas
Listen to learn more about the evolving landscape of rheumatoid arthritis treatment through the lens of the patient experience. One RA patient shares ...
Seizing The Healthy Aging Opportunity, With Prime Fifty’s Max Gowland
29 Jul 2025
Contributed by Lukas
Healthy aging has been identified as an important trend that consumer healthcare companies need to respond to. According to founder and managing direc...
Scrip's Five Must-Know Things - July 28, 2025
28 Jul 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended July 25, 2025. In this episode: Sanofi’s Vicebio buy; S...
Drug Fix: US FDA’s New Top Drug Regulator, Sarepta’s Options After Elevidys Stand-Off
25 Jul 2025
Contributed by Lukas
Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith and Editor-in-Chief Nielsen Hobbs discuss the issues awaiting George Tid...
MoonLake Leaders On Its Fast-Track Vision And $500m Deal
23 Jul 2025
Contributed by Lukas
MoonLake Immunotherapeutics is racing ahead in the biotech space with its innovative nanobody SLK and a transformative $500m non-dilutive financing de...
Scrip's Five Must-Know Things - July 22, 2025
22 Jul 2025
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the business week ended July 18, 2025. In this episode: – J&J delivers in Q2 de...
Scrip M&A Podcast: Is Biopharma M&A In A Holding Pattern Or A ‘New Normal’
21 Jul 2025
Contributed by Lukas
Scrip discusses the latest M&A activity and trends with CEO Shawn Titcomb of Allele Capital and Cheryl Reicin, a partner focused on international life...
Drug Fix: CBER Director’s Political Spin On COVID-19 Vaccines And US FDA RIFs Finalized
18 Jul 2025
Contributed by Lukas
Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs discuss why ...
Strategic Insights into the RNA Market
17 Jul 2025
Contributed by Lukas
Join Meredith Landry, Managing Editor of Citeline’s Custom Content, in conversation with Tom Hickey, Director of Therapeutic Strategy at Novotech, a...
Digital Health Roundup: Autonomous Robots, Medtronic’s Surgeon School, Sleep Tech & FDA Rules
16 Jul 2025
Contributed by Lukas
In this week's Digital Health Roundup, MedTech Insight's Marion Webb discusses her interview with Johns Hopkins researcher Axel Krieger who published ...
“They Are Able To Keep Their Body”: Medipost On Its Stem Cell Therapy Vision
16 Jul 2025
Contributed by Lukas
The latest episode of the In Vivo podcast features an interview Edward Ahn, CEO of Medipost, a Korean company that has developed stem cell therapies f...
Astellas Doubles Down on Gene Therapy Despite Industry Headwinds
15 Jul 2025
Contributed by Lukas
Astellas is doubling down on gene therapy while others retreat. Richard Wilson, SVP Primary Focus Lead, Genetic Regulation at Astellas, joins In Vivo ...